Testing a PET/CT scan for advanced stomach cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have adenocarcinoma (a specific type of cancer) of the stomach or where the esophagus meets the stomach (Siewert type III).
- You are at least 18 years old.
- Your cancer is advanced (stage T3-4b, N0-3, M0) but doctors believe it can be fully removed with surgery.
- You are planning to have surgery to remove your stomach (gastrectomy).
- You can lie still for about 30 minutes for a PET/CT scan, without claustrophobia or weight issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new imaging method called FAPI-PET to see if it can help find and understand tumors better than standard scans. It is for people with newly diagnosed stomach/esophageal cancer, pancreatic cancer, or those with unclear symptoms or scan results.
This trial uses two types of PET/CT scans (FDG and FAPI) to see how well chemotherapy or other treatments work before surgery for stomach cancer that has spread to the lining of the abdomen. The goal is to find the best way to measure treatment response and help guide your care.
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This trial looks at two types of scans—18F-FAPI PET/CT and MRI—to see how they compare for people with suspected or diagnosed gastric cancer. The goal is to learn which scan gives better information to help guide care.
Hear when a new Locally Advanced Gastric Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.